Efficacy News and Research

RSS
A.P. Pharma and Merial sign license and development agreement for a long-acting pain management product

A.P. Pharma and Merial sign license and development agreement for a long-acting pain management product

FluCide more effective than Tamiflu

FluCide more effective than Tamiflu

NSF International certification for COLD-FX(R)

NSF International certification for COLD-FX(R)

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Triamcinolone may be a treatment option for some patients with retinal vein occlusion

Triamcinolone may be a treatment option for some patients with retinal vein occlusion

Phase III results of Lauriad presented at the 49th Annual ICAAC

Phase III results of Lauriad presented at the 49th Annual ICAAC

Dominion develops and validates clinical quantitative assays for tapentadol

Dominion develops and validates clinical quantitative assays for tapentadol

New 'adjuvant' developed by scientists could allow the creation of important new vaccines

New 'adjuvant' developed by scientists could allow the creation of important new vaccines

Cell Therapeutics submits Pediatric Investigation Plan to EMEA for pixantrone

Cell Therapeutics submits Pediatric Investigation Plan to EMEA for pixantrone

Phase 2b trial of Mpex's Aeroquin with PARI Pharma's eFlow Nebulizer System successful

Phase 2b trial of Mpex's Aeroquin with PARI Pharma's eFlow Nebulizer System successful

FDA clears Diagnostic HYBRIDS' D3 FastPoint L-DFA Respiratory Virus Identification Kit

FDA clears Diagnostic HYBRIDS' D3 FastPoint L-DFA Respiratory Virus Identification Kit

BioAlliance announces Phase III results of miconazole Lauriad MBT for treatment of oropharyngeal candidiasis

BioAlliance announces Phase III results of miconazole Lauriad MBT for treatment of oropharyngeal candidiasis

Phase 1 trial results of Achaogen's ACHN-490 announced at ICAAC meeting

Phase 1 trial results of Achaogen's ACHN-490 announced at ICAAC meeting

Aeolus commences second study of AEOL 10150 against Acute Radiation Syndrome

Aeolus commences second study of AEOL 10150 against Acute Radiation Syndrome

Phase 2b clinical trial results of Dextofisopam to treat irritable bowel syndrome announced

Phase 2b clinical trial results of Dextofisopam to treat irritable bowel syndrome announced

Results from Keryx' KRX-0401 Phase 2 study to be presented at the International Kidney Cancer Symposium

Results from Keryx' KRX-0401 Phase 2 study to be presented at the International Kidney Cancer Symposium

Cytrx initiates tamibarotene and TRISENOX combination dose escalation study

Cytrx initiates tamibarotene and TRISENOX combination dose escalation study

Zabecor Pharmaceuticals initiates Phase II clinical trial of its Excellair asthma drug

Zabecor Pharmaceuticals initiates Phase II clinical trial of its Excellair asthma drug

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Protalix Biotherapeutics reports completion of its Phase III trial of prGCD

Protalix Biotherapeutics reports completion of its Phase III trial of prGCD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.